Status:
COMPLETED
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology
Lead Sponsor:
Institut Curie
Conditions:
Solid Tumor, Adult
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fifteen cohorts will be opened. Each cohort will explore one analysis method and/or tumoral type. Up to 50 patient can be included into each cohort.
Eligibility Criteria
Inclusion
- 18 years old or more
- Performance status from 0 to 4
- Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma.
- Informed consent form signed.
Exclusion
- Patient with history of other invasive cancer within 5 years.
- Patient treated for any non-invasive cancer
- Patient individually deprived of liberty or placed under the authority of a tutor
- Geographical condition potentially preventing compliance with the study protocol.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT02220556
Start Date
December 1 2010
End Date
June 1 2018
Last Update
August 8 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75005
2
Institut Mutualiste Montsouris
Paris, France, 75014
3
Institut Curie
Saint-Cloud, France, 92210